InterCure Ltd. (INCR)
NASDAQ: INCR · Real-Time Price · USD
1.311
+0.009 (0.69%)
Nov 21, 2025, 4:00 PM EST - Market closed
InterCure Market Cap
InterCure has a market cap or net worth of $73.31 million as of November 24, 2025. Its market cap has decreased by -9.41% in one year.
Market Cap
73.31M
Enterprise Value
112.60M
1-Year Change
-9.41%
Ranking
Category
Stock Price
$1.31
Market Cap Chart
Since December 16, 2010, InterCure's market cap has increased from $1.78M to $73.31M, an increase of 4,015.58%. That is a compound annual growth rate of 28.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 23, 2025 | 73.31M | -1.75% |
| Dec 31, 2024 | 74.61M | 27.32% |
| Dec 31, 2023 | 58.60M | -62.52% |
| Dec 29, 2022 | 156.35M | -47.90% |
| Dec 30, 2021 | 300.11M | 119.01% |
| Dec 31, 2020 | 137.03M | 17.13% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 948.84B |
| Johnson & Johnson | 491.26B |
| AbbVie | 417.60B |
| UnitedHealth Group | 289.84B |
| AstraZeneca | 280.49B |
| Novartis AG | 243.93B |
| Merck & Co. | 242.64B |
| Abbott Laboratories | 222.77B |